Division of Infectious Diseases

The Infectious Diseases Division (a sub-specialty of internal medicine) has 12 full-time faculty at the University of Utah Medical Center and 13 affiliated faculty at LDS, IMC, and the VA hospital who are actively involved in clinical, educational, and research endeavors in infectious diseases.

Clinical Care 

Our goal is to prevent, treat and care for patients with infectious diseases in both the inpatient and outpatient setting. The division provides general ID, HIV and immunocompromised inpatient consultation services at the University of Utah Medical Center and at LDS Hospital, IMC and the VA. The division also has active programs in antibiotic stewardship, infection control and early epidemic investigation.

In Clinic 1A, our providers see patients with general infectious disease problems such as osteomyelitis, septic arthritis and endocarditis. Specialty clinics, specializing in HIV, travel and tropical medicine, transplant infectious diseases, and immunology are available to better serve patients with those needs.

In addition, we run outreach clinics for HIV patients at the Utah prison and in St George and oversee the sexually transmitted disease clinic at the Salt Lake Valley Health Department.

Research

Our faculty are active in both laboratory and clinical research, with a focus on the pathogenesis of infectious diseases.

Our specific research interests include:

  1. Epstein Barr virus, Herpes Simplex Virus, HIV, and Kaposi’s sarcoma associated herpes virus.
  2. Opportunistic infections in immunocompromised hosts especially cytomegalovirus (CMV) and invasive fungal infections.
  3. Malaria and its complications; Geosentinel surveillance of infections in returning travelers.
  4. Viral triggers of multiple sclerosis.
  5. Antibiotic resistance, MRSA, and antibiotic stewardship.
  6. Immunology of diarrheal diseases and gut dysfunction in returning travelers

Latest News

Intensive Blood Pressure Control Could Prevent 100,000 Deaths Each Year
Research
Feb 13, 2017

Intensive Blood Pressure Control Could Prevent 100,000 Deaths Each Year

blood pressure, hypertension

Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S. each year. Experts from the University of Utah and institutions across the country built upon the landmark Systolic Blood Pressure Intervention Trial which found that decreasing blood pressure to 120 mmHg compared to 140 mmHg reduced heart attack, stroke and death in people that were at high risk. Until now, the number of lives that could be saved was unknown.... Read More

Select...
Genomes in Flux: New Study Reveals Hidden Dynamics of Bird and Mammal DNA Evolution
Research
Feb 06, 2017

Genomes in Flux: New Study Reveals Hidden Dynamics of Bird and Mammal DNA Evolution

genome, evolution

Evolution is often thought of as a gradual remodeling of the genome, the genetic blueprints for building an organism. But in some instances it might be more appropriate to call it an overhaul. Over the past 100 million years, the human lineage has lost one-fifth of its DNA, while an even greater amount was added, report scientists at the University of Utah School of Medicine. Until now, the extent to which our genome has expanded and contracted had been underappreciated. ... Read More

Human Genetics
Routinely Prescribed Antibiotic May Not Be Best for Treating Severe C. diff Infections
Research
Feb 06, 2017

Routinely Prescribed Antibiotic May Not Be Best for Treating Severe C. diff Infections

cdiff, hospital-acquired infection

Over the past two decades there has been a sharp rise in the number and severity of infections caused by the bacteria Clostridium difficile often shortened to C. diff now the most common hospital acquired infection in the United States. But a new study suggests that the most routinely prescribed antibiotic is not the best treatment for severe cases. Scientists at the VA Salt Lake City Health Care System and University of Utah report that patients with a severe C. diff infection (CDI) were less likely to die when treated with the antibiotic vancomycin compared to the standard treatment of metronidazole. ... Read More

Select...

Division Chief Sankar Swaminathan, MD

Read More

Read More

HELP PROGRESS, GIVE TODAY

You can help the Division of Infectious Diseases continue to progress with even a small contribution. Give today!